menu search

Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV

Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV
Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) (“Biostax”), a hub-and-spoke biotech development engine, announces the signing of a research collaboration agreement with Immgenuity, Inc. The joint research will focus on using Immgenuity’s IMTV014 and Biostax’s Lodonal™ and JKB-122 both independently and together to determine if […] The post Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV app... Read More
Posted: Aug 29 2023, 13:05
Author Name: forextv
Views: 092048

Search within

Pages Search Results: